[ad_1]
NEW YORK, January 29, 2022 (GLOBE NEWSWIRE) — Why: Rosen LLP, a global investor rights law firm, reminds purchases of Talis Biomedical Inc. (NASDAQ:TLIS) pursuant to and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) in connection with the Company’s February 2021 initial public offering (“IPO” or “Offer”), March 8, 2022 Lead Plaintiff Deadline.
So: If you have purchased Talis securities, you may be entitled to compensation through a contingency fee arrangement without any out-of-pocket charges or costs.
What to do next: To join the Talis class action lawsuit, visit http://www.rosenlegal.com/cases-register-2238.html Or call Phillip Kim, Esq.Toll Free 866-767-3653 or email pkim@rosenlegal.com or case@rosenlegal.com Information on class action lawsuits. A class action lawsuit has been filed.If you wish to be the lead plaintiff, you must move the court No later than March 8, 2022. The lead plaintiff is the representative party directing the litigation on behalf of the other class members.
Why choose the Rosen method: We encourage investors to choose a qualified attorney with a successful track record in…
The full story is available on Benzinga.com
[ad_2]
Source link
